Basic Stats
| CIK | 1849380 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to OneMedNet Corporation - Equity Warrant
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40386 ONEMEDNET C |
|
| August 13, 2025 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-276130 Prospectus Supplement No. 1 (To Prospectus dated July 24, 2025) Primary Offering of Up to 11,500,000 Shares of Common Stock Secondary Offering of Up to 28,152,560 Shares of Common Stock This prospectus supplement updates, amends and supplements the prospectus dated July 24, 2025 (the “Prospectus”), which forms a part of our Registration |
|
| July 25, 2025 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-276130 PROSPECTUS ONEMEDNET CORPORATION Primary Offering of Up to 11,500,000 Shares of Common Stock Secondary Offering of Up to 28,152,560 Shares of Common Stock This prospectus relates to the primary issuance by us of up to an aggregate of 11,500,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), of OneMedNet Corpora |
|
| July 14, 2025 |
Letter Agreement, dated May 19, 2025, between the Company and Slickage Studios LLC. Exhibit 10.30 May 19, 2025 Re: Conversion of Certain Outstanding Balances to OneMedNet Corporation Common Stock Dear James, This letter agreement (this “Agreement”) sets forth the terms under which OneMedNet Corporation (the “Company”) offers to settle certain debts owed to Slickage Studios LLC (“Slickage”) through the issuance of 250,000 shares (“Shares”) of the Company’s common stock, par value |
|
| July 14, 2025 |
As filed with the Securities and Exchange Commission on July 11, 2025 As filed with the Securities and Exchange Commission on July 11, 2025 Registration No. |
|
| July 11, 2025 |
Exhibit 99.1 |
|
| July 11, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 11, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fil |
|
| July 8, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File |
|
| July 8, 2025 |
Exhibit 99.1 |
|
| June 25, 2025 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) 333-276130 OneMedNet Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities* Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees to Be Paid Equity Common stock, par value $0. |
|
| June 25, 2025 |
As filed with the Securities and Exchange Commission on June 24, 2025 As filed with the Securities and Exchange Commission on June 24, 2025 Registration No. |
|
| June 24, 2025 |
Exhibit 10.4 June [●], 2025 Re: Conversion of Certain Outstanding Balances to OneMedNet Corp. Common Stock Dear [●], This letter agreement (this “Agreement”) sets forth the terms under which OneMedNet Corporation (the “Company”) offers to settle its debt owed to you through the issuance of and aggregate of [●] shares (“Shares”) of the Company’s common stock, par value $0.0001 per share, determined |
|
| June 24, 2025 |
Exhibit 10.3 SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is made and entered as of June [●], 2025, by and between [●] (the “Purchaser”) and OneMedNet Corporation (the “Company”). WHEREAS, Purchaser desires to make an additional investment in the Company to fund working capital and other general corporate purposes of the Company; and WHEREAS, as the investment, Purchaser d |
|
| June 24, 2025 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of June [●], 2025, by and between ONEMEDNET CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and the investor identified on the signature page hereto (including its succ |
|
| June 24, 2025 |
Exhibit 10.2 June [●], 2025 [●] Address: [●] Email: [●] Re: OneMedNet Corporation [●]: This letter agreement is intended to memorialize the understandings and agreements that we have reached with you relating to, among other things, the Board of Directors (the “Board”) of OneMedNet Corporation, a Delaware corporation (the “Company”). For good and valuable consideration, including other agreements |
|
| June 24, 2025 |
Exhibit 4.1 PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK ONEMEDNET CORPORATION Warrant Shares: [●] Original Issuance Date: June [●], 2025 THIS PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, [●] or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set f |
|
| June 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 17, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40386 ONEMEDNET |
|
| April 15, 2025 |
Exhibit 19 |
|
| April 15, 2025 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 10, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 15, 2025 |
Form of Notice of Grant of Restricted Stock Units & Restricted Stock Unit Award Agreement. Exhibit 10.26 OneMedNet Corporation NOTICE OF GRANT OF RESTRICTED STOCK UNITS The Participant has been granted the number of Restricted Stock Units set forth below (the “RSUs”) pursuant to the OneMedNet Corporation 2022 Equity Incentive Plan (the “Plan”), as follows: Participant: Date of Grant: Number of Restricted Stock Units: Initial Vesting Start Date: Vested Common Shares: [●] Subject to Parti |
|
| April 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 ONEMEDNET CORP |
|
| April 1, 2025 |
SEC File Number: 001-40386 CUSIP Number: 68270C103 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 14, 2025 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 12, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fi |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 25, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| February 10, 2025 |
OneMedNet Corporation 2022 Equity Incentive Plan Exhibit 99.1 ONEMEDNET CORPORATION 2022 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the OneMedNet Corporation 2022 Equity Incentive Plan (the “Plan”) is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby Directors, officers, Employees, and Consultants (and prospective Directors, officers, Employees, and Consultan |
|
| February 10, 2025 |
As filed with the Securities and Exchange Commission on February 10, 2025 As filed with the Securities and Exchange Commission on February 10, 2025 Registration No. |
|
| February 10, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) ONEMEDNET CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock Rule 457(c) and Rule 457(h) 3,043,486 (2) $ 0. |
|
| February 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| February 3, 2025 |
As filed with the Securities and Exchange Commission on January 31, 2025 As filed with the Securities and Exchange Commission on January 31, 2025 Registration No. |
|
| February 3, 2025 |
Form of Registration Rights Agreement. Exhibit 10.25 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January , 2025, is by and between OneMedNet Corp, a Delaware corporation (the “Company”), and Dr. Thomas Kosasa, an individual (the “Investor”). RECITALS WHEREAS, the Company and the Investor have entered into (i) a Loan Agreement, dated January 2, 2024 (the “January 2024 Loan Agreement”) |
|
| February 3, 2025 |
Form of Amendment to Pre-Funded Warrant. Exhibit 4.6 AMENDMENT TO PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK This Amendment to Pre-Funded Warrant to Purchase Shares of Common Stock (this “Amendment”) is made as of January , 2025 and effective as of September 24, 2024, by and between OneMedNet Corporation (the “Company”) and Off the Chain, LP (the “Investor”). RECITALS WHEREAS, the Company issued to the Investor a Pre-Funded Wa |
|
| February 3, 2025 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-1 (Form Type) OneMedNet Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities* Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Carry Forward Form Type Carry Forward File Number Carry Forward Initial effective date Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward Newly Registered Securities Fees Previously Paid Equity Common stock, par value $0. |
|
| February 3, 2025 |
Form of Amendment to Securities Purchase Agreement. Exhibit 10.24 AMENDMENT TO SECURITIES PURCHASE AGREEMENT This Amendment to Securities Purchase Agreement (this “Amendment”) is made as of January , 2025 and effective as of September 24, 2024, by and between OneMedNet Corporation (the “Company”) and Off the Chain, LP (the “Investor”). RECITALS WHEREAS, the Company and the Investor entered into a Securities Purchase Agreement dated September 24, 20 |
|
| December 30, 2024 |
OneMedNet Regains Compliance with NASDAQ Periodic Filing Requirements Exhibit 99.1 OneMedNet Regains Compliance with NASDAQ Periodic Filing Requirements MINNEAPOLIS, December 30, 2024 (GLOBENEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWD™”), inclusive of electronic health records, laboratory results and, uniquely, medical i |
|
| December 30, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 23, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| December 20, 2024 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 19, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| December 17, 2024 |
OneMedNet Corporation Compensation Recovery Policy Exhibit 10.8 OneMedNet Corporation Compensation Recovery Policy (Adopted November 6, 2024) The Board has determined that it is in the best interests of the Company and its stockholders to adopt this Policy enabling the Company to recover from specified current and former Company executives certain incentive-based compensation in the event of an accounting restatement resulting from material noncom |
|
| December 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40386 ONEMED |
|
| December 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40386 ONEMEDNET C |
|
| December 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40386 ONEMEDNET |
|
| November 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 21, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| November 27, 2024 |
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q Exhibit 99.1 OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q MINNEAPOLIS, November 27, 2024 (GLOBENEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWD™”), inclusive of electronic health records, laboratory results and, uniquely, medica |
|
| November 22, 2024 |
ONEMEDNET CORPORATION INDEX TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.1 ONEMEDNET CORPORATION INDEX TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Balance Sheets F-1 Unaudited Consolidated Statements of Operations F-2 Unaudited Consolidated Statements of Changes in Temporary Equity and Stockholders’ Deficit F-3 Unaudited Consolidated Statements of Cash Flows F-4 Notes to the Unaudited Consolidated Financial Statements F-5 ONEMEDNET C |
|
| November 22, 2024 |
Exhibit 99.3 Management’s Discussion and Analysis of Financial Condition and Results of Operations Company Overview Founded in 2009, we provide innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing our proven OneMedNet iRWD™ solution, we securely de-identifies, searches, and curates a data archive locally, bringing a |
|
| November 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 7, 2023 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorpora |
|
| November 15, 2024 |
SEC File Number: 001-40386 CUSIP Number: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 12, 2024 |
ONMD / OneMedNet Corporation / COWEN AND COMPANY, LLC - COWEN AND COMPANY, LLC Passive Investment SC 13G 1 onmd111224.htm COWEN AND COMPANY, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 OneMedNet Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 68270C103 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appr |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 4, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001- |
|
| October 17, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 16, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| October 15, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 8, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission F |
|
| October 7, 2024 |
OneMedNet Announces Board Member Transition to Drive Growth Post-IPO Exhibit 99.1 OneMedNet Announces Board Member Transition to Drive Growth Post-IPO MINNEAPOLIS, OCTOBER 2, 2024 (GLOBE NEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic refresh of its Board of Directors following the successful transition to a publicly traded entity. This |
|
| October 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 1, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission F |
|
| October 1, 2024 |
Exhibit 4.2 PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK ONEMEDNET CORPORATION Warrant Shares: Original Issuance Date: September , 2024 THIS PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, |
|
| October 1, 2024 |
Exhibit 4.1 WARRANT TO PURCHASE SHARES OF COMMON STOCK ONEMEDNET CORPORATION Warrant Shares: Original Issuance Date: September , 2024 THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or afte |
|
| October 1, 2024 |
Exhibit 10.2 AMENDMENT TO REGISTRATION RIGHTS AGREEMENT THIS AMENDMENT TO REGISTRATION RIGHTS AGREEMENT (this “Amendment”), is made as of September , 2024, by and among OneMedNet Corporation (the “Company”), and (the “Investor”). RECITALS WHEREAS, the Company and the Investor entered into a Registration Rights Agreement dated July 23, 2024 (the “Agreement”); and WHEREAS, the Company and the Invest |
|
| October 1, 2024 |
Exhibit 99.1 Joint Filing Agreement EX-99.1 2 otc241037ex99-1.htm JOINT FILING AGREEMENT Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of |
|
| October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 24, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commissio |
|
| October 1, 2024 |
OneMedNet Announces Additional $1.7 Million Private Placement Exhibit 99.1 OneMedNet Announces Additional $1.7 Million Private Placement MINNEAPOLIS, September 26, 2024 (GLOBENEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into a securit |
|
| October 1, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of September , 2024, by and between ONEMEDNET CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and each investor identified on the signature pages hereto (each, includin |
|
| October 1, 2024 |
Exhibit 10.3 AMENDMENT TO VOTING AGREEMENT THIS AMENDMENT TO VOTING AGREEMENT (this “Amendment”), is made as of September , 2024, by and among OneMedNet Corporation (the “Company”), and (the “Investor”). RECITALS WHEREAS, the Company and the Investor entered into a Voting Agreement dated July 23, 2024 (the “Agreement”); and WHEREAS, the Company and the Investor desire to amend the Agreement as set |
|
| October 1, 2024 |
ONMD / OneMedNet Corporation / Off the Chain Capital, LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* OneMedNet Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 68270C103 (CUSIP Number) September 25, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the r |
|
| September 12, 2024 |
OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q Exhibit 99.1 OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q MINNEAPOLIS, September 12, 2024 (GLOBENEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received |
|
| September 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 9, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| August 30, 2024 |
Exhibit 10.1 CONSULTING AGREEMENT This CONSULTING AGREEMENT (“Agreement”) is entered into as of August 30, 2024 (“Effective Date”) by and between OneMedNet Corporation, a Delaware corporation (the “Company”) and Robert Golden (“Consultant”). 1. SERVICES. 1.1 Services. Consultant shall be available to perform the function of a Chief Financial Officer (“Services”). The Board or Chief Executive Offic |
|
| August 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 26, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission F |
|
| August 16, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 15, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission F |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission F |
|
| August 5, 2024 |
ONMD / OneMedNet Corporation / DISCOVERY CAPITAL MANAGEMENT, LLC / CT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| July 29, 2024 |
Exhibit 4.1 PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK ONEMEDNET CORPORATION Warrant Shares: Original Issuance Date: July , 2024 THIS PRE-FUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (this “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at an |
|
| July 29, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of July , 2024, by and between ONEMEDNET CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and each investor identified on the signature pages hereto (each, including its |
|
| July 29, 2024 |
Exhibit 10.3 July , 2024 [Investor] Address: Attn: Email: Re: OneMedNet Corporation Ladies and Gentlemen: This letter agreement is intended to memorialize the understandings and agreements that we have reached with you relating to, among other things, the Board of Directors (the “Board”) of OneMedNet Corporation, a Delaware corporation (the “Company”). For good and valuable consideration, includin |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fil |
|
| July 29, 2024 |
Exhibit 99.1 OneMedNet Announces $4.6 Million Private Placement Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management MINNEAPOLIS, July 26, 2024 (GLOBENEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records, laboratory resul |
|
| July 29, 2024 |
Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) dated as of July , 2024 is made by and between , a (the “Investor”), and OneMedNet Corporation, a company incorporated under the laws of the State of Delaware (the “Company”). The Investor and the Company may be referred to herein individually as a “Party” and collectively as the “Parties.” WHEREAS, th |
|
| June 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 24, 2024 |
Exhibit 99.1 OneMedNet Provides Updates on Auditor Change and Announces Related Receipt of Nasdaq Notice Regarding Delayed Form 10-Q - Regains compliance with Nasdaq minimum closing bid price rule – - Secures financing from institutional investor to support aggressive growth plans - MINNEAPOLIS, June 24, 2024 (BUSINESSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the |
|
| June 21, 2024 |
Exhibit 10.1 STANDBY EQUITY PURCHASE AGREEMENT THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of June 17, 2024 is made by and between YA II PN, LTD., a Cayman Islands exempt limited partnership (the “Investor”), and ONEMEDNET CORPORATION, a company incorporated under the laws of the state of Delaware (the “Company”). The Investor and the Company may be referred to herein indivi |
|
| June 21, 2024 |
Exhibit 10.2 NEITHER THIS NOTE NOR THE SECURITIES INTO WHICH THIS NOTE IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THESE SECURITIES HAVE BEEN SOLD IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSU |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 21, 2024 |
Exhibit 10.4 TERMINATION AGREEMENT This Termination Agreement (this “Agreement”), effective as of June 14, 2024, is made between ONEMEDNET CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and Helena Global Investment Opportunities 1 Ltd. (together with its successors and assigns, the “Lead Investor”). RECITALS WHEREAS, the Company and the Lead Investor |
|
| June 21, 2024 |
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) dated as of June 17, 2024 is made by and between YA II PN, LTD., a Cayman Islands exempt limited partnership (the “Investor”), and OneMedNet Corporation, a company incorporated under the laws of the State of Delaware (the “Company”). The Investor and the Company may be referred to herein individually a |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File |
|
| June 6, 2024 |
Exhibit 10.1 AMENDMENT TO THE SECURITIES PURCHASE AGREEMENT This Amendment to the Securities Purchase Agreement (this “Amendment”), effective as of June 4, 2024, is made between ONEMEDNET CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and each investor identified on the signature pages hereto (each, including its successors and assigns, an “Investor” |
|
| June 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File |
|
| May 23, 2024 |
OneMedNet Corporation Corporate Presentation Exhibit 99.1 |
|
| May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: April 30,2025 Estimated average burden hours per response. 2.50 FORM 12b-25 SEC FILE NUMBER 001-41102 NOTIFICATION OF LATE FILING CUSIP NUMBER (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transit |
|
| May 10, 2024 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File |
|
| May 7, 2024 |
Exhibit 10.4 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of the Closing Date (as defined in the Merger Agreement, as defined below) by and between (i) Data Knights Acquisition Corp., a Delaware corporation (including any successor entity thereto, the “Purchaser”), and (ii) (the “Subject Party”). Any capitalized term used but not defined in this A |
|
| May 7, 2024 |
Lockup Agreement by certain OneMedNet equity holders. Exhibit 10.3 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of the Closing Date (as defined in the Merger Agreement, as defined below) by and between (i) Data Knights Acquisition Corp., a Delaware corporation (including any successor entity thereto, the “Purchaser”), and (ii) (the “Subject Party”). Any capitalized term used but not defined in this A |
|
| May 7, 2024 |
Specimen Warrant Certificate of Data Knights Acquisition Corp. Exhibit 4.4 Form of Warrant Certificate [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW DATA KNIGHTS ACQUISITION CORP. Incorporated Under the Laws of the State of Delaware CUSIP [ ] Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the regist |
|
| May 7, 2024 |
Employment Agreement between OneMedNet Corporation and Aaron Green, President. Exhibit 10.8 OneMedNet Corporation April 18, 2023 Dear Aaron Green, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be President and will have dual reporting to the CEO and the Chairman of the Board. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, con |
|
| May 7, 2024 |
As filed with the Securities and Exchange Commission on May 6, 2024 As filed with the Securities and Exchange Commission on May 6, 2024 Registration No. |
|
| May 7, 2024 |
Exhibit 10.5 May 6, 2021 Data Knights Acquisition Corp. Trident Court, 1 Oakcroft Road Chessington, Surrey KT9 1BD United Kingdom Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) to be entered into by and between Data Knights Acquisition Corp., a Delaware co |
|
| May 7, 2024 |
Exhibit 21.1 Subsidiaries Data Knights Merger Sub, Inc. Delaware |
|
| May 7, 2024 |
Sponsor Support Agreement dated as of April 25, 2022. Exhibit 10.7 Execution Version SUBSCRIPTION ESCROW AGREEMENT This Subscription Escrow Agreement (the “Escrow Agreement”) is entered into and effective the 28th day of March 2024, by and among OneMedNet Corporation, a corporation organized under the laws of the State of Delaware (“OneMedNet”); each investor identified on the signature pages hereto (each, including his, her or theirs successors and |
|
| May 7, 2024 |
Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of March 28, 2024, by and between ONEMEDNET CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and each investor identified on the signature pages hereto (each, including |
|
| May 7, 2024 |
Exhibit 10.12 REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 28, 2024, is by and among OneMedNet Corporation, a Delaware corporation (the “Company”), and each of the investors to the Securities Purchase Agreement (as defined below) (collectively, the “Investors” and, together with the Company, the “Parties” and each, a “Party”). Certain capit |
|
| May 7, 2024 |
Exhibit 14.1 ONEMEDNET CORPORATION CODE OF ETHICS AND BUSINESS CONDUCT POLICY (Adopted November 8, 2023) I. INTRODUCTION The Board of Directors (the “Board”) of OneMedNet Corporation (the “Company”) has adopted this code of ethics and business conduct policy (this “Code”), as amended from time to time by the Board, and which is applicable to all of the Company’s directors, officers and employees ( |
|
| May 7, 2024 |
Specimen Unit Certificate of Data Knights Acquisition Corp. Exhibit 4.2 UNITS SEE REVERSE FOR CERTAIN DEFINITIONS DATA KNIGHTS ACQUISITION CORP. CUSIP [*] UNITS CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE WARRANT THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one share of Class A common stock, with a par value $0.0001 per share (“Class A Common Stock”), of Data Knights Acquisition Corp., a Delaware corporation (the “C |
|
| May 7, 2024 |
Form of OneMedNet Corporation 2022 Equity Incentive Plan. Exhibit 10.1 DATA KNIGHTS ACQUISITION CORP.1 2022 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the Data Knights Acquisition Corp. 2022 Equity Incentive Plan (the “Plan”) is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby Directors, officers, Employees, and Consultants (and prospective Directors, officers, Emplo |
|
| May 7, 2024 |
Specimen Class A Common Stock Certificate of Data Knights Acquisition Corp. Exhibit 4.3 UNITS SEE REVERSE FOR CERTAIN DEFINITIONS DATA KNIGHTS ACQUISITION CORP. CUSIP [*] UNITS CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE WARRANT THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one share of Class A common stock, with a par value $0.0001 per share (“Class A Common Stock”), of Data Knights Acquisition Corp., a Delaware corporation (the “C |
|
| May 7, 2024 |
Form of Registration Rights Agreement by certain OneMedNet equity holders. Exhibit 10.2 FORM OF REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 7, 2023 (the “Effective Date”) by and among (i) Data Knights Acquisition Corp., a Delaware corporation (including its successors, the “Purchaser”), and (ii) and the undersigned parties listed on Exhibit A hereto (each such party, together with any person |
|
| May 7, 2024 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) ONEMEDNET CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Title of each Class of Securities to be Registered Fee calculation rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee(2) Equity Common Stock, $0. |
|
| May 7, 2024 |
Employment Agreement between OneMedNet Corporation and Lisa Embree, Chief Financial Officer. Exhibit 10.9 OneMedNet Corporation October 19, 2023 Dear Lisa Embree, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be Chief Financial Officer, reporting to the CEO. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, consulting or other business activi |
|
| May 7, 2024 |
Securities Purchase Agreement dated June 28, 2023 with OneMedNet Corporation. Exhibit 10.10 OneMedNet Corporation March 28, 2022 Paul Casey 1010 Wilder Avenue Apt. 1301 Honolulu, HI 96822 Dear Paul, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be CEO and you will report to the Board of Directors. This is a full-time, exempt position. While you render services to the Company, you will not engage in an |
|
| May 7, 2024 |
Amended and Restated Bylaws of OneMedNet Corporation. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ONEMEDNET CORPORATION (THE “CORPORATION”) (Adopted November 8, 2023) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as |
|
| May 7, 2024 |
Exhibit 10.13 Execution Version SUBSCRIPTION ESCROW AGREEMENT This Subscription Escrow Agreement (the “Escrow Agreement”) is entered into and effective the 28th day of March 2024, by and among OneMedNet Corporation, a corporation organized under the laws of the State of Delaware (“OneMedNet”); each investor identified on the signature pages hereto (each, including his, her or theirs successors and |
|
| May 7, 2024 |
Third Amended and Restated Certificate of Incorporation of OneMedNet Corporation. Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ONEMEDNET CORPORATION November 8, 2023 OneMedNet Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Data Knights Acquisition Corp” and hereby changes its name to “OneMedNet Corporation” The original cer |
|
| May 7, 2024 |
Exhibit 4.1 WARRANT AGREEMENT between DATA KNIGHTS ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY THIS WARRANT AGREEMENT (this “Agreement”), dated as of [ ], 2021, is by and between Data Knights Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to |
|
| May 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 17, 2024 |
Exhibit 14.1 ONEMEDNET CORPORATION CODE OF ETHICS AND BUSINESS CONDUCT POLICY (Adopted November 8, 2023) I. INTRODUCTION The Board of Directors (the “Board”) of OneMedNet Corporation (the “Company”) has adopted this code of ethics and business conduct policy (this “Code”), as amended from time to time by the Board, and which is applicable to all of the Company’s directors, officers and employees ( |
|
| April 17, 2024 |
As filed with the Securities and Exchange Commission on April 16, 2024 As filed with the Securities and Exchange Commission on April 16, 2024 Registration No. |
|
| April 17, 2024 |
Third Amended and Restated Certificate of Incorporation of OneMedNet Corporation. Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ONEMEDNET CORPORATION November 8, 2023 OneMedNet Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Data Knights Acquisition Corp” and hereby changes its name to “OneMedNet Corporation” The original cer |
|
| April 17, 2024 |
Exhibit 10.2 FORM OF REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 7, 2023 (the “Effective Date”) by and among (i) Data Knights Acquisition Corp., a Delaware corporation (including its successors, the “Purchaser”), and (ii) and the undersigned parties listed on Exhibit A hereto (each such party, together with any person |
|
| April 17, 2024 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) ONEMEDNET CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Title of each Class of Securities to be Registered Fee calculation rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee(2) Equity Common Stock, $0. |
|
| April 17, 2024 |
Exhibit 10.10 OneMedNet Corporation March 28, 2022 Paul Casey 1010 Wilder Avenue Apt. 1301 Honolulu, HI 96822 Dear Paul, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be CEO and you will report to the Board of Directors. This is a full-time, exempt position. While you render services to the Company, you will not engage in an |
|
| April 17, 2024 |
Employment Agreement between OneMedNet Corporation and Lisa Embree, Chief Financial Officer. Exhibit 10.9 OneMedNet Corporation October 19, 2023 Dear Lisa Embree, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be Chief Financial Officer, reporting to the CEO. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, consulting or other business activi |
|
| April 17, 2024 |
Exhibit 10.3 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of the Closing Date (as defined in the Merger Agreement, as defined below) by and between (i) Data Knights Acquisition Corp., a Delaware corporation (including any successor entity thereto, the “Purchaser”), and (ii) (the “Subject Party”). Any capitalized term used but not defined in this A |
|
| April 17, 2024 |
Amended and Restated Bylaws of OneMedNet Corporation. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ONEMEDNET CORPORATION (THE “CORPORATION”) (Adopted November 8, 2023) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as |
|
| April 17, 2024 |
Securities Purchase Agreement dated June 28, 2023 with OneMedNet Corporation. Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of this 28th day of June 2023, is by and among Data Knights Acquisition Corp, a Delaware corporation with offices located at Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA11 4FN (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (i |
|
| April 17, 2024 |
Employment Agreement between OneMedNet Corporation and Aaron Green, President. Exhibit 10.8 OneMedNet Corporation April 18, 2023 Dear Aaron Green, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be President and will have dual reporting to the CEO and the Chairman of the Board. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, con |
|
| April 9, 2024 |
Exhibit 10.5 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of the Closing Date (as defined in the Merger Agreement, as defined below) by and between (i) Data Knights Acquisition Corp., a Delaware corporation (including any successor entity thereto, the “Purchaser”), and (ii) (the “Subject Party”). Any capitalized term used but not defined in this A |
|
| April 9, 2024 |
Exhibit 4.1 DESCRIPTION OF SECURITIES OneMedNet Corporation (“we,” “us,” “our,” or the “Company”) has two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): common stock, par value $0.0001 per share (“Common Stock”), and warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11. |
|
| April 9, 2024 |
Exhibit 21 Subsidiaries 1. The Company’s wholly-owned subsidiary, OneMedNet Solutions Corporation, a Delaware corporation, founded on October 13, 2009 in the State of Hawaii and later incorporated in the State of Delaware on November 20, 2015 and 2. OneMedNet Solutions Corporation’s wholly-owned subsidiary, OneMedNet Technologies (Canada) Inc., incorporated on October 16, 2015 under the provisions |
|
| April 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 ONEMEDNET CORP |
|
| April 9, 2024 |
Exhibit 10.4 FORM OF REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 7, 2023 (the “Effective Date”) by and among (i) Data Knights Acquisition Corp., a Delaware corporation (including its successors, the “Purchaser”), and (ii) and the undersigned parties listed on Exhibit A hereto (each such party, together with any person |
|
| April 2, 2024 |
Exhibit 99.1 OneMedNet Announces CEO Succession Plan ~ President, Aaron Green, Assumes Role of Chief Executive Officer ~ ~ CEO, Paul Casey, Announces Retirement and Shift to Active Advisory Role to Guide Transition Successfully ~ ~ Casey to Remain on Board Post-Transition ~ April 2, 2024 Minneapolis, MN – (ACCESSWIRE) OneMedNet Corporation (Nasdaq: ONMD), the leading curator of regulatory-grade im |
|
| April 2, 2024 |
Exhibit 99.2 OneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth ~ Cash Infusion Provides Significant Cash Runway of Up to $4.54 Million ~ Minneapolis, MN – April 2, 2024. OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“iRWDTM”), through its proven OneMedNet iRWD™ solution, |
|
| April 2, 2024 |
Exhibit 10.3 Execution Version SUBSCRIPTION ESCROW AGREEMENT This Subscription Escrow Agreement (the “Escrow Agreement”) is entered into and effective the 28th day of March 2024, by and among OneMedNet Corporation, a corporation organized under the laws of the State of Delaware (“OneMedNet”); each investor identified on the signature pages hereto (each, including his, her or theirs successors and |
|
| April 2, 2024 |
Exhibit 10.2 EXECUTION VERSIOn REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 28, 2024, is by and among OneMedNet Corporation, a Delaware corporation (the “Company”), and each of the investors to the Securities Purchase Agreement (as defined below) (collectively, the “Investors” and, together with the Company, the “Parties” and each, a “Party |
|
| April 2, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of March 28, 2024, by and between ONEMEDNET CORPORATION, a corporation organized under the laws of the State of Delaware (the “Company”), and each investor identified on the signature pages hereto (each, including |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fi |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR Commission File Number: 001-40386 For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| March 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 14, 2024 |
US68270C1036 / ONEMEDNET CORP A / Westchester Capital Management, LLC - SC 13G/A Passive Investment SC 13G/A 1 ef20021392sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* ONEMEDNET CORPORATION (f/k/a DATA KNIGHTS ACQUISITION CORP.) (Name of Issuer) Class A Common Stock, $0.0001 par value per share (Title of Clas |
|
| February 9, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| February 5, 2024 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* OneMedNet Corporation (f/k/a Data Knights Acquisition Corp.) (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 68270C103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check th |
|
| January 3, 2024 |
Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2023 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| January 3, 2024 |
Exhibit 99.1 December 29, 2023 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Commissioners: We have read the statements made by OneMedNet Corporation (formerly known as Data Knights Acquisition Corp.) included under Item 4.01 of its Form 8-K dated December 29, 2023. We agree with the statements concerning our Firm under Item 4.01. We are |
|
| December 18, 2023 |
Third Amended and Restated Certificate of Incorporation of OneMedNet Corporation. Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ONEMEDNET CORPORATION November 8, 2023 OneMedNet Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Data Knights Acquisition Corp” and hereby changes its name to “OneMedNet Corporation” The original cer |
|
| December 18, 2023 |
Amended and Restated Bylaws of OneMedNet Corporation. Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ONEMEDNET CORPORATION (THE “CORPORATION”) (Adopted November 8, 2023) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as |
|
| December 18, 2023 |
Exhibit 10.2 FORM OF REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 7, 2023 (the “Effective Date”) by and among (i) Data Knights Acquisition Corp., a Delaware corporation (including its successors, the “Purchaser”), and (ii) and the undersigned parties listed on Exhibit A hereto (each such party, together with any person |
|
| December 18, 2023 |
Employment Agreement between OneMedNet Corporation and Lisa Embree, Chief Financial Officer. Exhibit 10.9 OneMedNet Corporation October 19, 2023 Dear Lisa Embree, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be Chief Financial Officer, reporting to the CEO. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, consulting or other business activi |
|
| December 18, 2023 |
Exhibit 10.3 FORM OF LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of the Closing Date (as defined in the Merger Agreement, as defined below) by and between (i) Data Knights Acquisition Corp., a Delaware corporation (including any successor entity thereto, the “Purchaser”), and (ii) (the “Subject Party”). Any capitalized term used but not defined in this A |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2023 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Commission |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 O |
|
| December 18, 2023 |
Exhibit 14.1 ONEMEDNET CORPORATION CODE OF ETHICS AND BUSINESS CONDUCT POLICY (Adopted November 8, 2023) I. INTRODUCTION The Board of Directors (the “Board”) of OneMedNet Corporation (the “Company”) has adopted this code of ethics and business conduct policy (this “Code”), as amended from time to time by the Board, and which is applicable to all of the Company’s directors, officers and employees ( |
|
| December 18, 2023 |
Exhibit 107 Calculation of Filing Fee Tables FORM S-1 (Form Type) ONEMEDNET CORPORATION (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Title of each Class of Securities to be Registered Amount Registered Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price(1) Amount of Registration Fee(2) Common Stock, $0. |
|
| December 18, 2023 |
Securities Purchase Agreement dated June 28, 2023 with OneMedNet Corporation. Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of this 28th day of June 2023, is by and among Data Knights Acquisition Corp, a Delaware corporation with offices located at Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA11 4FN (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (i |
|
| December 18, 2023 |
Employment Agreement between OneMedNet Corporation and Paul Casey, Chief Executive Officer. Exhibit 10.10 OneMedNet Corporation March 28, 2022 Paul Casey 1010 Wilder Avenue Apt. 1301 Honolulu, HI 96822 Dear Paul, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be CEO and you will report to the Board of Directors. This is a full-time, exempt position. While you render services to the Company, you will not engage in an |
|
| December 18, 2023 |
Employment Agreement between OneMedNet Corporation and Aaron Green, President. Exhibit 10.8 OneMedNet Corporation April 18, 2023 Dear Aaron Green, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be President and will have dual reporting to the CEO and the Chairman of the Board. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, con |
|
| December 18, 2023 |
As filed with the Securities and Exchange Commission on December 15, 2023 As filed with the Securities and Exchange Commission on December 15, 2023 Registration No. |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2023 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| November 22, 2023 |
Exhibit 99.1 OneMedNet Announces Participation as an Exhibitor in the AI Showcase During the RSNA 2023 Annual Meeting Minneapolis, MN – November 20, 2023, OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of regulatory-grade imaging Real World Data (“RWD”), today announced its Technical Exhibit during the Radiological Society of North America’s (“RSNA”) 2023 Annual Meeting fr |
|
| November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 ONEME |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR Commission File Number: 001-40386 For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| November 13, 2023 |
Exhibit 10.9 OneMedNet Corporation October 19, 2023 Dear Lisa Embree, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be Chief Financial Officer, reporting to the CEO. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, consulting or other business activi |
|
| November 13, 2023 |
Exhibit 99.4 OneMedNet Completes Business Combination with Data Knights Acquisition Corp. to Become a Publicly Traded Company OneMedNet Common Stock to Trade on Nasdaq Under Ticker “ONMD” Today, Wednesday, November 8, 2023 OneMedNet to Fully Embark on its Growth Strategy as it Spearheads the Imaging RWD Solution in the $400 Billion Clinical Market Minneapolis, MN – November 8, 2023, OneMedNet Corp |
|
| November 13, 2023 |
Exhibit 14.1 ONEMEDNET CORPORATION CODE OF ETHICS AND BUSINESS CONDUCT POLICY (Adopted November 8, 2023) I. INTRODUCTION The Board of Directors (the “Board”) of OneMedNet Corporation (the “Company”) has adopted this code of ethics and business conduct policy (this “Code”), as amended from time to time by the Board, and which is applicable to all of the Company’s directors, officers and employees ( |
|
| November 13, 2023 |
Exhibit 99.5 OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients ~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~ Minneapolis, MN – November 9, 2023, OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of regulatory-grade |
|
| November 13, 2023 |
Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of this 28th day of June 2023, is by and among Data Knights Acquisition Corp, a Delaware corporation with offices located at Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA11 4FN (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (i |
|
| November 13, 2023 |
Exhibit 99.2 INDEX TO FINANCIAL STATEMENTS Financial Statements Consolidated Balance Sheets 2 Consolidated Statements of Operations 3 Consolidated Statements of Stockholders’ Equity (Deficit) 4 Consolidated Statements of Cash Flows 5 Notes to the Consolidated Financial Statements 6 1 OneMedNet Corporation Consolidated Balance Sheets June 30, 2023 and December 31, 2022 2023 2022 Assets Current Asse |
|
| November 13, 2023 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.1 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Defined terms included below shall have the same meaning as terms defined and included elsewhere in this proxy statement/prospectus. Introduction The following unaudited pro forma condensed combined financial statements of Data Knights present the combination of the historical financial information of Data Knights and OneMed |
|
| November 13, 2023 |
Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF ONEMEDNET CORPORATION (THE “CORPORATION”) (Adopted November 8, 2023) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as |
|
| November 13, 2023 |
Exhibit 10.8 OneMedNet Corporation April 18, 2023 Dear Aaron Green, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be President and will have dual reporting to the CEO and the Chairman of the Board. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, con |
|
| November 13, 2023 |
Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ONEMED NET CORPORATION November 8, 2023 OneMedNet Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Data Knights Acquisition Corp” and hereby changes its name to “OneMedNet Corporation” The original ce |
|
| November 13, 2023 |
Exhibit 10.10 OneMedNet Corporation March 28, 2022 Paul Casey 1010 Wilder Avenue Apt. 1301 Honolulu, HI 96822 Dear Paul, OneMedNet Corp. (the “Company”) is pleased to offer you employment on the following terms: 1. Position. Your title will be CEO and you will report to the Board of Directors. This is a full-time, exempt position. While you render services to the Company, you will not engage in an |
|
| November 13, 2023 |
Exhibit 99.3 Management’s Discussion and Analysis of Financial Condition and Results of Operations for OneMedNet Corp The following discussion and analysis of the financial condition and results of operations of OneMedNet should be read together with OneMedNet’s audited financial statements for the years ended December 31, 2022 and 2021, in each case together with related notes (Notes 1-11) theret |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2023 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission |
|
| November 13, 2023 |
Exhibit 99.6 OneMedNet Announces Members of Senior Management to Attend ISPOR Europe 2023 Conference ~ Introduces OneMedNet’s Exclusive iRWD™ Solution to a Global Community of Healthcare Professionals ~ Minneapolis, MN – November 10, 2023, OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“RWD”), today announced th |
|
| October 18, 2023 |
Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Co |
|
| October 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Co |
|
| October 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Co |
|
| October 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Co |
|
| October 12, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, October 12, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company’s |
|
| October 12, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, October 12, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company’s |
|
| October 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Co |
|
| October 12, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Co |
|
| October 10, 2023 |
Exhibit 99.1 DATA KNIGHTS ACQUISITION CORP. PLEASE DO NOT RETURN THE PROXY CARD IF YOU ARE VOTING ELECTRONICALLY. INTERNET/MOBILE – www.cstproxyvote.com Use the Internet to vote your proxy. Have your proxy card available when you access the above website. Follow the prompts to vote your shares. Vote at the Meeting – If you plan to attend the virtual online special meeting, you will need your 12 di |
|
| October 10, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Com |
|
| October 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Com |
|
| October 10, 2023 |
Exhibit 99.1 DATA KNIGHTS ACQUISITION CORP. PLEASE DO NOT RETURN THE PROXY CARD IF YOU ARE VOTING ELECTRONICALLY. INTERNET/MOBILE – www.cstproxyvote.com Use the Internet to vote your proxy. Have your proxy card available when you access the above website. Follow the prompts to vote your shares. Vote at the Meeting – If you plan to attend the virtual online special meeting, you will need your 12 di |
|
| October 2, 2023 |
TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(3) Registration File No. 333-266274 SEPTEMBER 21, 2023 PROXY STATEMENT OF DATA KNIGHTS ACQUISITION CORP. PROSPECTUS FOR UP TO SHARES OF COMMON STOCK To the Stockholders of Data Knights Acquisition Corp.: We are very pleased to provide this proxy statement/prospectus relating to the proposed merger (the “Merger”) of Data Knights Merger Sub, Inc., a |
|
| September 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 ( |
|
| September 25, 2023 |
Exhibit 99.1 OneMedNet Corporation and Data Knights Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Data Knights’ Special Meeting to Approve Proposed Business Combination Special Meeting of Data Knights Acquisition Corp. Stockholder to Approve Business Combination Scheduled for October 17, 2023 Shareholders of Record as of September 20, 2023, are Eligible to Vote at |
|
| September 25, 2023 |
Exhibit 99.1 OneMedNet Corporation and Data Knights Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Data Knights’ Special Meeting to Approve Proposed Business Combination Special Meeting of Data Knights Acquisition Corp. Stockholder to Approve Business Combination Scheduled for October 17, 2023 Shareholders of Record as of September 20, 2023, are Eligible to Vote at |
|
| September 25, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 ( |
|
| September 21, 2023 |
As filed with the United States Securities and Exchange Commission on September 21, 2023 TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on September 21, 2023 Registration No. |
|
| September 21, 2023 |
September 21, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N. |
|
| September 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 ( |
|
| September 18, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 ( |
|
| September 18, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, September 18, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, (the “Company”), announced today that it caused to be deposited $75,000 into the Company’s |
|
| September 18, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, September 18, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, (the “Company”), announced today that it caused to be deposited $75,000 into the Company’s |
|
| August 28, 2023 |
As filed with the United States Securities and Exchange Commission on August 28, 2023 Table of Contents As filed with the United States Securities and Exchange Commission on August 28, 2023 Registration No. |
|
| August 28, 2023 |
NELSON MULLINS RILEY & SCARBOROUGH LLP ATTORNEYS AND COUNSELORS AT LAW Andrew M. Tucker T: 202.689.2987 [email protected] 101 Constitution Ave, NW, Suite 900 Washington, DC 20001 T: 202.689.2800 F: 202.689.2860 nelsonmullins.com August 28, 2023 Via EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attention: Ms. Taylor Beec |
|
| August 14, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, August 11, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, today announced that it caused to be deposited $75,000 into the Company’s trust account, allow |
|
| August 14, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 Data K |
|
| August 14, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, August 11, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, today announced that it caused to be deposited $75,000 into the Company’s trust account, allow |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Com |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Com |
|
| August 11, 2023 |
Amendment No. 2 to Investment Management Trust Agreement Exhibit 10.1 AMENDMENT NO. 2 TO INVESTMENT MANAGEMENT TRUST AGREEMENT THIS AMENDMENT NO. 2 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT (this “Amendment”) is made as of August 11, 2023, by and between Data Knights Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee” and together with the Company, the “Parti |
|
| August 11, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Announces Charter and Trust Agreement Amendments and Extension of Deadline to Complete a Business Combination Minneapolis, MN and London, UK, August 11, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, (the “Company”), announced today that its stockholders approv |
|
| August 11, 2023 |
Exhibit 3.1 SECOND AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DATA KNIGHTS ACQUISITION CORP. August 11, 2023 Data Knights Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is Data Knights Acquisition Corp. The Corporation’s Certificate |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Com |
|
| August 11, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Announces Charter and Trust Agreement Amendments and Extension of Deadline to Complete a Business Combination Minneapolis, MN and London, UK, August 11, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCU, DKDCA, DKDCW), a special purpose acquisition company, (the “Company”), announced today that its stockholders approv |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2023 DATA KNIGHTS ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Com |
|
| August 11, 2023 |
Exhibit 3.1 SECOND AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DATA KNIGHTS ACQUISITION CORP. August 11, 2023 Data Knights Acquisition Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is Data Knights Acquisition Corp. The Corporation’s Certificate |
|
| August 11, 2023 |
Amendment No. 2 to Investment Management Trust Agreement Exhibit 10.1 AMENDMENT NO. 2 TO INVESTMENT MANAGEMENT TRUST AGREEMENT THIS AMENDMENT NO. 2 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT (this “Amendment”) is made as of August 11, 2023, by and between Data Knights Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee” and together with the Company, the “Parti |
|
| August 8, 2023 |
Master Reseller Agreement dated May 22, 2015 Exhibit 10.19 |
|
| August 8, 2023 |
Data License Agreement dated September 16, 2021 Exhibit 10.18 |
|
| August 8, 2023 |
As filed with the United States Securities and Exchange Commission on August 8, 2023 TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on August 8, 2023 Registration No. |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Amendment No. 1 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defini |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Amendment No. 2 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defini |
|
| August 2, 2023 |
As filed with the United States Securities and Exchange Commission on August 1, 2023 TABLE OF CONTENTS As filed with the United States Securities and Exchange Commission on August 1, 2023 Registration No. |
|
| August 1, 2023 |
NELSON MULLINS RILEY & SCARBOROUGH LLP ATTORNEYS AND COUNSELORS AT LAW Andrew M. Tucker T: 202.689.2987 [email protected] 101 Constitution Ave, NW, Suite 900 Washington, DC 20001 T: 202.689.2800 F: 202.689.2860 nelsonmullins.com August 1, 2023 Via EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attention: Ms. Taylor Beech |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Commi |
|
| July 31, 2023 |
Data Knights Acquisition Corp Announces Calling of Special Meeting of Stockholders Exhibit 99.1 Data Knights Acquisition Corp Announces Calling of Special Meeting of Stockholders Minneapolis, MN and London, UK – July 31, 2023 - Data Knights Acquisition Corp. (“Data Knights”) (Nasdaq: DKDCA), a publicly traded special purpose acquisition company, today announced that it will be calling a special meeting of its stockholders to be held on August 11, 2023 at 1:00 p.m. ET via live we |
|
| July 31, 2023 |
Data Knights Acquisition Corp Announces Calling of Special Meeting of Stockholders Exhibit 99.1 Data Knights Acquisition Corp Announces Calling of Special Meeting of Stockholders Minneapolis, MN and London, UK – July 31, 2023 - Data Knights Acquisition Corp. (“Data Knights”) (Nasdaq: DKDCA), a publicly traded special purpose acquisition company, today announced that it will be calling a special meeting of its stockholders to be held on August 11, 2023 at 1:00 p.m. ET via live we |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Commi |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| July 12, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / July 12, 2023 / Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCA), a special purpose acquisition company, today announced that it caused to be deposited $122,920 into the Company’s Trust account, allowi |
|
| July 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2023 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Commi |
|
| July 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2023 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Commi |
|
| July 12, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / July 12, 2023 / Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCA), a special purpose acquisition company, today announced that it caused to be deposited $122,920 into the Company’s Trust account, allowi |
|
| July 5, 2023 |
Executive Employment Agreement with Paul Casey Exhibit 10.15 OneMedNet Corporation Suite 250, 6385 Old Shady Oak Road Eden Prairie, MN 55344 USA Tel: 1-800-918-7189 www.onemednet.com June 1, 2022 Attention: Paul Casey 1010 Wilder Ave, Apt 804 Honolulu, HI 96822 Dear Paul Casey, On behalf of OneMedNet Corporation (the “Company”), I am pleased to make you an offer of employment to join our team. This letter sets forth the terms and conditions of |
|
| July 5, 2023 |
As filed with the United States Securities and Exchange Commission on July 3, 2023 Table of Contents As filed with the United States Securities and Exchange Commission on July 3, 2023 Registration No. |
|
| July 5, 2023 |
Securities Purchase Agreement dated June 28, 2023 Exhibit 10.20 REDACTED COPY Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private and confidential. SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of this 28th day of June 2023, is by and among Data Knights Acquisition Corp, a Delaware corporation with of |
|
| July 5, 2023 |
Promissory Note dated June 30, 2023 Exhibit 10.21 DATA KNIGHTS ACQUISITION CORP. PROMISSORY NOTE $500,000 June 30, 2023 FOR VALUE RECEIVED, Data Knights Acquisition Corp., a Delaware corporation, (herein called the “Company”), hereby promises to pay to EF Hutton, division of Benchmark Investments, LLC (herein called the “Holder”), the principal sum of five hundred thousand dollars ($500,000). In the case of an event of default, this |
|
| July 5, 2023 |
Exhibit 3.4 FORM OF STATE OF DELAWARE CERTIFICATE OF MERGER OF DOMESTIC CORPORATION Pursuant to Tile 8, Section 251(c) of the Delaware General Corporation Law (“DGCL”), the undersigned corporation executed the following Certificate of Merger as of , 2023: FIRST: Data Knights Merger Sub, Inc., a Delaware corporation (the “Merged Corporation”) is merging with and into OneMedNet Corporation, a Delawa |
|
| July 5, 2023 |
Employment Agreement with Doug Arent Exhibit 10.16 OneMedNet Corporation Suite 250, 6385 Old Shady Oak Road Eden Prairie, MN 55344 USA Tel: 1-800-918-7189 www.onemednet.com April 14, 2020 Attention: Doug Arent 33175 Timber Ridge Rd Evergreen, CO 80439 Dear Doug: On behalf of OneMedNet Corporation (the “Company”), I am pleased to make you an offer of employment to join our team. This letter sets forth the terms and conditions of your |
|
| July 5, 2023 |
Employment Agreement with Aaron Green Exhibit 10.17 OneMedNet Corporation 6385 Old Shady Oak Road Suite 250 Eden Prairie, MN 55344 January 13, 2022 Saurabh Mathur 5045 Shiloh Crossing Way Cumming, Georgia 30040 (770) 298-7875 [email protected] Delivered via Email Dear Saurabh, When executed by you and the company this will constitute a letter agreement (“Agreement”) confirming the terms and conditions under which OneMedNet Co |
|
| July 5, 2023 |
Satisfaction and Discharge Agreement dated June 28, 2023 Exhibit 10.22 SATISFACTION AND DISCHARGE OF INDEBTEDNESS PURSUANT TO UNDERWRITING AGREEMENT DATED MAY 6, 2021 JUNE 28, 2023 This Satisfaction and Discharge of Indebtedness (the “Satisfaction and Discharge”) is made and entered into to be effective as of June 28, 2023, by and between Data Knights Acquisition Corp., a Delaware corporation (the “Company”), OneMedNet Corporation, a Delaware Corporatio |
|
| July 3, 2023 |
NELSON MULLINS RILEY & SCARBOROUGH LLP ATTORNEYS AND COUNSELORS AT LAW Andrew M. Tucker T: 202.689.2987 [email protected] 101 Constitution Ave, NW, Suite 900 Washington, DC 20001 T: 202.689.2800 F: 202.689.2860 nelsonmullins.com July 3, 2023 Via EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Attention: Ms. Taylor Beech M |
|
| June 13, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, June 12, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCA), a special purpose acquisition company, today announced that it caused to be deposited $122,920 into the Company’s Trust account, allowing the Company |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2023 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Commi |
|
| June 13, 2023 |
Exhibit 99.1 Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination Minneapolis, MN and London, UK, June 12, 2023 – Data Knights Acquisition Corp. (“Data Knights” or the “Company”) (Nasdaq: DKDCA), a special purpose acquisition company, today announced that it caused to be deposited $122,920 into the Company’s Trust account, allowing the Company |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2023 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40386 86-2076743 (Commi |
|
| May 19, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 Data |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-CEN o Form N-CSR Commission File Number: 001-40386 For Period Ended: March 31, 2023 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on |
|
| April 11, 2023 |
As filed with the United States Securities and Exchange Commission on April 10, 2023 Table of Contents As filed with the United States Securities and Exchange Commission on April 10, 2023 Registration No. |
|
| April 11, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Data Knights Acquisition Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 237699103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| April 11, 2023 |
Data License Agreement dated September 16, 2021 Exhibit 10.18 OneMedNet Corporation · 6385 Old Shady Oak Road, Suite 250 · Eden Prairie, MN 55344 · www.onemednet.com Order # 09212733 3. Payment erms: T Monthly, according to Accepted data set fulfillments and according to pricing in Section 2, Queries & Fees. 4. A ditional erms d Order Form T Total Price $341,467.00 1. Data License Agreement: This Order m e s d s t h n For (“Order Form”) s d y i |
|
| April 11, 2023 |
Master Reseller Agreement dated May 22, 2015 Exhibit 10.19 REDACTED COPY Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private and confidential. [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [Omitted] [ |
